{"id":58958,"date":"2017-05-30T00:00:00","date_gmt":"2017-05-30T05:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/"},"modified":"2017-05-30T00:00:00","modified_gmt":"2017-05-30T05:00:00","slug":"internal-medicine-research-non-research-awards-2","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/","title":{"rendered":"Internal Medicine Research & Non Research Awards"},"content":{"rendered":"

Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost<\/p>\n

Zolty, Ronald, Observational Registry of Treatment Patterns in U.S. Heart Failure Patients with Reduced Ejection Fraction(CHAMPS-HF), 20419, Novartis Pharmaceuticals Corporation, 02\/21\/17-03\/30\/20, $132,921, $33,779, $166,700<\/p>\n

Zolty, Ronald, PIONEER STUDY: A multicenter, randomized, double-blind, double dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril and valsartan (LCZ696) versusenalapril on changes in NT-proBNP and safety and, 20195, Novartis Pharmaceuticals Corporation02\/23\/17-06\/30\/18$0, $422,582,$22,823, $445,405<\/p>\n

Olivera-Martinez, Marco A, TARGET-HCC: A 5-year Longitudinal Observational Study of Patients with Hepatacellular Cancer, 20609, TARGET PharmaSolutions, 03\/22\/17-03\/21\/22, $335,329, $86,926, $422,255<\/p>\n

Rochling, Fedja A, A randomized, double-blind, placebo controlled, 2- part, adaptive design, multicenter 12-week study to assess safety, tolerability and efficacy of LJN452 in patients with non-alcoholic steatohepatitis, 20133Novartis Pharmaceuticals Corporation, 12\/31\/16-04\/30\/19, $120,345, $30,510, $150,855<\/p>\n

Rochling, Fedja A, TARGET-NASH: A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis (NASH), 20513, TARGET PharmaSolutions, 01\/26\/17-01\/25\/22, $152,674, $39,435, $192,109<\/p>\n

Rochling, Fedja A, TARGET-PBC: A 5-year Longitudinal Observational Study of Patients with Primary Biliary Cholangitis,20512, TARGET PharmaSolutions,01\/30\/17-01\/29\/22, $186,615, $48,260, $234,875<\/p>\n

Singh, Shailender, Pancreatic Cystic Reference Set20827University of Pittsburgh05\/17\/16-03\/31\/17, $8,364, $3,036, $11,400<\/p>\n

Kalil, Andre C, (ARLG) Antibacterial Resistance Leadership Group: Achaogen Lung PK, 20336, Duke University, 06\/01\/16-11\/30\/16, $11,411, $5,763, $17,174<\/p>\n

Sandkovsky, Uriel Sebastian,Risk Factors for Development of CMV Resistance in Solid Organ Transplantation, 20173, Merck & Co, Inc., 10\/18\/16-10\/17\/17, $20,272, $6,590, $26,862<\/p>\n

Swindells, Susan, Title III:Categorical Grant Program to Provide Outpatient Early Intervention Services with Respect to HIV Disease (Ryan White Part C Outpatient EIS Program, 6247, DHHS\/HRSA, 01\/01\/16-12\/31\/17, $397,573, $0, $397,573<\/p>\n

Swindells, Susan, AIDS Clinical Trials Group Network (ACTG), 16481, Brigham & Women's Hospital, 12\/01\/16-11\/30\/17, $50,400, $25,452, $75,852<\/p>\n

Swindells, Susan, AIDS Clinical Trials Group (ACTG): Protocol Chair Support, 20097, Brigham & Women's Hospital12\/01\/16-11\/30\/17, $12,500, $6,312, $18,812<\/p>\n

Swindells, Susan, A Phase III, randomized, multicenter, parallel-group, noninferiority, open-label study evaluating the efficacy, safety, and tolerability of switching to long-acting cabotegravir plus longacting rilpivirine from current INI- NNRTI-, or PI-based…, 20165, GlaxoSmithKline12\/28\/16-12\/27\/17, $231,418, $56,252, $287,670<\/p>\n

Swindells, Susan, A Phase III, Randomized, Multicenter, Parallel-group, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Long-Acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch from an …, 20164, GlaxoSmithKline, 12\/28\/16-12\/27\/17, $317,560, $82,306, $399,866<\/p>\n

Swindells, Susan, Title III: Categorical Grant Program to Provide Outpatient Early Intervention Services with Respect to HIV Disease (Ryan White Part C Outpatient EIS Program)6247DHHS\/HRSA01\/01\/17-12\/31\/17, $378,574, $0, $378,574,<\/p>\n

Zimmer, Andrea Joan, MAT Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles, 20530, Astellas Pharma Global Development, Inc., 03\/22\/17-03\/21\/21, $36,649, $8,749, $45,398<\/p>\n

Zimmer, Andrea Joan, PMC A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species, 20529, Astellas Pharma Global Development, Inc., 03\/22\/17-03\/21\/21, $6,514, $914, $7,428<\/p>\n

Miles, Clifford Douglas, Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix® (belatacept)-based Immunosuppression, 19933, Bristol-Meyers Squibb Pharmaceutical Research Institute, 11\/04\/16-12\/31\/18, $276,228, $71,559, $347,787<\/p>\n

Plumb, Troy John, Prospective Multicenter, Open Label, Non-Randomized, Cross-Over Study Evaluating the Use of the Tablo? Hemodialysis System In-Center and In-Home by Subjects with End Stage Renal Disease (ESRD) who are on Stable Dialysis Regimens (TABLO), 18916, Outset Medical, Inc., 01\/30\/17-01\/31\/18, $$96,232, $24,370, $120,602<\/p>\n

Holstein, Sarah A, Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma20623DHHS\/NIH\/NCI08\/12\/16-12\/31\/17, $18,916, $9,552, $28,468<\/p>\n

Lunning, Matthew A, Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell\/Myeloma Fusions20239, National Marrow Donor Program, 08\/19\/16-08\/18\/20, $73,392, $0, $73,392<\/p>\n

Marr, Alissa Sue, The Targeted Agent and Profiling Utilization Registry (TAPUR) Study, 19872, American Society of Clinical Oncology [ASCO], 10\/07\/16-10\/06\/19, $16,283, $3,714, $19,997<\/p>\n

Vose, Julie M,A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classical Hodgkin Lymphoma, 19969, Merck Sharp & Dohme Corp.01\/03\/17-07\/31\/19, $139,200, $35,542, $174,742<\/p>\n

Grant, Kathleen M, Intensive Referral to Al-Anon: Benefits to Concerned Others and Their Drinkers, 20806, Palo Alto Institute for Research and Education, Inc., 09\/01\/16-06\/30\/17, $77,138, $38,954, $116,092<\/p>\n

Murphy, Peter James, A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System, 20461, Cincinnati Children's Hospital Medical Center, 07\/01\/16-12\/31\/16, $13,889, $1,111, $15,000<\/p>\n

Nordgren, Tara Marie, Role of dietary microRNAs on human macrophage function, 20502, University of Nebraska – Lincoln12\/01\/16-05\/31\/17, $27,624, $0, $27,624<\/p>\n

Nordgren, Tara Marie, Food For Health Seed Grant: Prevention of human disease by food-borne microRNAs (EPSCoR), 20451, University of Nebraska – Lincoln, 01\/01\/17-04\/30\/18, $16,501, $0, $16,501<\/p>\n

Thompson, Austin Bassett, Uptravi (SelexiPag): The Users Drug Registry (SPHERE), 20328, Actelion Pharmaceuticals US, Inc., 11\/22\/16-11\/21\/17, $31,248, $7,344, $38,592<\/p>\n

Thompson, Austin Bassett,An Open-Label Extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease20198United Therapeutics Corporation01\/25\/17-01\/24\/18, $46,621, $11,341, $57,962<\/p>\n

Thompson, Austin Bassett, A Multicenter, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension, 20197United Therapeutics Corporation01\/25\/17-01\/24\/18, $48,411, $11,807, $60,218<\/p>\n

Michaud, Kaleb D, The risks of mortality, cardiovascular events, and diabetes associated with statin use in patients with rheumatoid arthritis, 20158, Pfizer, Inc., 12\/16\/16-12\/15\/17, $119,667, $30,333, $150,000<\/p>\n

Thiele, Geoffrey Milton, Malondialdehyde-Acetaldehyde (MAA) Adducts and Anti-MAA Antibodies in Abatacept Treatment Response in Rheumatoid Arthritis (RA), 20146, Bristol-Myers Squibb Company, 12\/19\/16-12\/18\/17, $109,065, $32,720, $141,785<\/p>\n<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"

ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.<\/p>\n","protected":false},"author":124,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-58958","post","type-post","status-publish","format-standard","hentry","category-uncategorized","department-internal-medicine-newsletter"],"yoast_head":"\nInternal Medicine Research & Non Research Awards<\/title>\n<meta name=\"description\" content=\"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Internal Medicine Research & Non Research Awards\" \/>\n<meta property=\"og:description\" content=\"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-30T05:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Selaba Travis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Selaba Travis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\"},\"author\":{\"name\":\"Selaba Travis\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/9ba8ea33b9f004c1f40c442e639004cd\"},\"headline\":\"Internal Medicine Research & Non Research Awards\",\"datePublished\":\"2017-05-30T05:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\"},\"wordCount\":778,\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\",\"name\":\"Internal Medicine Research & Non Research Awards\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\"},\"datePublished\":\"2017-05-30T05:00:00+00:00\",\"description\":\"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unmc.edu\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Internal Medicine Research & Non Research Awards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"contentUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/unmcedu\",\"https:\/\/x.com\/unmc\",\"https:\/\/instagram.com\/iamunmc\",\"https:\/\/www.youtube.com\/user\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/9ba8ea33b9f004c1f40c442e639004cd\",\"name\":\"Selaba Travis\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/author\/c8ffe9a587b126f152ed3d89a146b445\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Internal Medicine Research & Non Research Awards","description":"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/","og_locale":"en_US","og_type":"article","og_title":"Internal Medicine Research & Non Research Awards","og_description":"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.","og_url":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"2017-05-30T05:00:00+00:00","author":"Selaba Travis","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"Selaba Travis","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/"},"author":{"name":"Selaba Travis","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/9ba8ea33b9f004c1f40c442e639004cd"},"headline":"Internal Medicine Research & Non Research Awards","datePublished":"2017-05-30T05:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/"},"wordCount":778,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/","url":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/","name":"Internal Medicine Research & Non Research Awards","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"datePublished":"2017-05-30T05:00:00+00:00","description":"ADIS reported funding for Internal Medicine from 01\/01\/2017- To 03\/31\/2017.","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/2017\/05\/30\/internal-medicine-research-non-research-awards-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"Internal Medicine Research & Non Research Awards"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/9ba8ea33b9f004c1f40c442e639004cd","name":"Selaba Travis","url":"https:\/\/www.unmc.edu\/newsroom\/author\/c8ffe9a587b126f152ed3d89a146b445\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/58958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/124"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=58958"}],"version-history":[{"count":0,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/58958\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=58958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=58958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=58958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}